Results 31 to 40 of about 1,418,021 (124)

Prenatal exposure to buprenorphine or methadone: effects on physical growth, neurological development and temperament in early childhood. [PDF]

, 2012
Pharmaceutical maintenance with methadone is the current gold standard for pregnant women with opioid-dependence. While there are many benefits of methadone, its use during pregnancy is associated with high rates of neonatal abstinence syndrome, and long
Whitham, Justine N.
core  

Healthcare Costs and Resource Use Among Chronic Low‐Back Pain Patients Treated With Belbuca or Buprenorphine Transdermal Patches: A Retrospective US Medicare Claims Analysis

Pain Research and Management, Volume 2025, Issue 1, 2025.
Objectives: To compare the economic burden of Medicare patients diagnosed with chronic low‐back pain (cLBP) treated with Belbuca (buprenorphine buccal film) or buprenorphine transdermal patches in the US healthcare setting. Methods: This study was performed using Merative MarketScan Medicare claims (2018–2021).
Vladimir Zah, Filip Stanicic, Djurdja Vukicevic, Dimitrije Grbic, Shashank Kaushik   +4 more
wiley   +1 more source

Twelve-year trend in treatment seeking for buprenorphine abuse in Finland

, 2013
BACKGROUND: Buprenorphine abuse is becoming increasingly common worldwide. However, large-scale long-term studies of buprenorphine abuse are lacking. The objective of this study was to examine the trend in characteristics of clients seeking treatment for
Uosukainen, Hanna, Bell, J Simon, Paasolainen, Mika, Kauhanen, Jussi, Ifeoma N. Onyeka, J. Simon Bell, Laitinen, Kirsti, Jaana Föhr, Hanna Uosukainen, Kirsti Laitinen, Jari Tiihonen, Voutilainen, Sari, Mika Paasolainen, Tiihonen, Jari, Onyeka, Ifeoma N., Fohr, Jaana, Sari Voutilainen, Jussi Kauhanen, Bell, J. Simon, Onyeka, Ifeoma N   +19 more
core   +1 more source

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals

Substance Abuse and Rehabilitation, 2016
Lynn R Webster,1 Michael Camilleri,2 Andrew Finn3 1PRA Health Sciences, Salt Lake City, UT, 2Mayo Clinic Rochester, MN, 3BioDelivery Sciences, Inc., Raleigh, NC, USA Abstract: Buprenorphine and buprenorphine–naloxone fixed combinations are ...
Webster LR, Camilleri M, Finn A
doaj  

Opioid analgesics for nociceptive cancer pain: A comprehensive review

CA: A Cancer Journal for Clinicians, Volume 74, Issue 3, Page 286-313, May/June 2024.
Abstract Pain is one of the most burdensome symptoms in people with cancer, and opioid analgesics are considered the mainstay of cancer pain management. For this review, the authors evaluated the efficacy and toxicities of opioid analgesics compared with placebo, other opioids, nonopioid analgesics, and nonpharmacologic treatments for background cancer
Christina Abdel Shaheed, Christopher Hayes, Christopher G. Maher, Jane C. Ballantyne, Martin Underwood, Andrew J. McLachlan, Jennifer H. Martin, Sujita W. Narayan, Mark A. Sidhom   +8 more
wiley   +1 more source

Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats

, 2017
Objectives The objective of this study was to compare the pharmacokinetics of compounded and commercially available aqueous formulations of buprenorphine after a single buccal dose to healthy cats and to evaluate the concentrations of a compounded ...
Karen K Cornell, Heather Lindell, Brett M Gulledge, Chad W Schmiedt, Kristen M Messenger   +4 more
core   +1 more source

Opioid analgesics prescribing trends 2010–2019 in Slovenia: National database study

Human Psychopharmacology: Clinical and Experimental, Volume 39, Issue 2, March 2024.
Abstract Objective Significant increases in global opioid use have been reported in recent decades. This study analyzed opioid utilization in outpatient care in Slovenia between 2010 and 2019. Methods This retrospective cross‐sectional study performed a nationwide database analysis of all outpatient opioid analgesic prescriptions based on Slovenian ...
Nanca Cebron Lipovec
wiley   +1 more source

Beyond-Use Date Determination of Buprenorphine Buccal Solution Using a Stability-Indicating High-Performance Liquid Chromatographic Assay

, 2015
Objectives The objectives of this study included developing and validating a stability-indicating high-performance liquid chromatographic (HPLC) method with ultraviolet (UV) detection for the determination of buprenorphine in a buccal solution for ...
Kirk, Loren Madden, Brown, Stacy D.
core   +1 more source

Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain

Journal of Pain Research, 2019
Joseph V Pergolizzi Jr,1,2 Robert B Raffa3,4 1NEMA Research, Inc., Naples, FL, USA; 2Neumentum, Palo Alto, CA, USA; 3University of Arizona College of Pharmacy, Tucson, AZ, USA; 4Department of Pharmaceutical Sciences, Temple University School of Pharmacy,
Pergolizzi Jr JV, Raffa RB
doaj  

Buprenorphine Treatment for Opioid Use Disorder: An Examination of Benefits and Barriers. [PDF]

The opioid crisis has continued relentlessly throughout the twenty-first century. In order to reduce negative impacts of the opioid crisis, we must increase use of highly effective, FDA-approved medications for opioid use disorder (MOUDs) – including ...
Golan, Olivia K
core   +1 more source